GLP-3 Retatrutide (12mg vials)

Description

Retatrutide is a synthetic peptide of interest in metabolic and receptor-signaling research. It is structurally engineered to act as a triple agonist, engaging the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor from a single molecular scaffold. This combined multi-receptor profile makes it a frequently referenced tool in studies exploring how overlapping incretin and energy-balance pathways interact at the cellular level.

Because it converges on three distinct receptor families, Retatrutide is commonly used to investigate downstream signaling cascades, comparative receptor binding, and the in vitro behavior of pathways relevant to glucose handling and energy metabolism. It is studied alongside related single- and dual-agonist peptides to characterize differences in pathway activation and structure-activity relationships.

Each unit from Bolt Peptide is supplied as a sterile-filtered, lyophilized powder sealed in a glass vial at a 12mg fill weight. Material is intended for reconstitution in an appropriate laboratory solvent by trained personnel working in a controlled research setting.

• Receptor signaling and multi-agonist pathway investigations
• Comparative peptide chemistry and structure-activity studies
• In vitro models of glucose and energy-metabolism pathways
• Reference and method-development applications

Purity is verified by HPLC and mass spectrometry, and a batch-specific Certificate of Analysis (COA) is available to document identity and purity for full research traceability. For best stability, store the sealed lyophilized vial cool, dry, and protected from light, with long-term storage at -20°C; keep reconstituted material refrigerated, shield it from light, and avoid repeated freeze-thaw cycles.

Research Use Only: This material is supplied strictly for laboratory research. Not for human or animal consumption. It is not a drug, food, supplement, or cosmetic and has not been approved by the FDA.